← FDA Drug Approvals (Drugs@FDA)
TAFLUPROST
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SANDOZ · Approved 2022-01-28
Drug application
- FDA Application #
ANDA209040- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TAFLUPROST
- Generic name
- TAFLUPROST
- Active ingredients
- TAFLUPROST
- Dosage form
- SOLUTION/DROPS
- Route
- OPHTHALMIC
- Marketing status
- Prescription
- Sponsor
- SANDOZ
- Manufacturer
- Sandoz Inc
- First approval
- 2022-01-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown